Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$34.82 - $39.26 $696 - $785
-20 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$36.05 - $42.76 $324 - $384
9 Added 81.82%
20 $0
Q4 2018

Jan 25, 2019

BUY
$31.89 - $38.44 $350 - $422
11 New
11 $0
Q3 2018

Oct 23, 2018

SELL
$29.25 - $36.73 $292 - $367
-10 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$28.49 - $35.06 $284 - $350
10 New
10 $0

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.11B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.